Drug Channels

OCTOBER 13, 2020

I am pleased to announce our new 2020–21 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. Click here to download a free report overview (including the Table of Contents and a List of Exhibits) New Drug Channels Institute Study Examines Impact of COVID-19 on U.S.

Pharmaceuticals 52

Pharmaceuticals Licensing Licensing Pharmacy 52

DrugBank

AUGUST 20, 2024

If you're a pharmaceutical researcher or drug developer, understanding these breakthroughs is critical to staying at the forefront of innovation. Addressing Industry Challenges We then dig into the broader challenges the pharmaceutical industry is facing in drug discovery and development.

Therapies 72

Therapies Pharmaceuticals Disease Research 72

Drug Channels

MARCH 15, 2022

Pharmacies and Pharmacy Benefit Managers , available for purchase and immediate download. Click here to download a free report overview (including key industry trends, the Table of Contents, and a List of Exhibits) New Drug Channels Institute Study Examines Consolidation and Vertical Integration of U.S. Click to Enlarge].

Pharmacy 84

Pharmacy Specialty Pharmacies Licensing Licensing 84

Drug Channels

SEPTEMBER 3, 2024

Download the brochure. The Healthcare Innovation Company's Value-Based Care Summit In-Person Event | October 28 - 29, 2024 in Washington, DC Use promo code VBCDC to save $100. Register Today.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Government Regulations 52

Drug Channels

OCTOBER 23, 2023

A program driven by market dynamics and led by champions of channel strategy, join now to master the complexities of pharmacy and distribution models to accelerate market access –It's all happening December 11-13, 2023. Why should you attend this pivotal event? How is health policy affecting the distribution channel?

Pharmacy 61

Pharmacy Biosimilars Production Marketing 61

The Pharma Data

JANUARY 6, 2021

… Biopharmaceutical products represent up to 20 percent of the total pharmaceutical market and are growing at a rate of nearly eight percent annually. DOWNLOAD TO LEARN MORE>>>> Source link. DOWNLOAD TO LEARN MORE>>>> Source link. .

Pharmaceuticals 52

Pharmaceuticals Production Marketing 52

The Pharma Data

OCTOBER 19, 2020

20, 2020 /PRNewswire/ — CNS PHARMACEUTICALS AG , Inc. manufacturer, Pharmaceutics International, Inc. (“Pii”), has completed the manufacturing process for Berubicin Drug Product, its lead drug candidate for the treatment of glioblastoma multiforme (GBM), an aggressive form of brain cancer currently considered incurable.

Clinical Trials 52

Clinical Trials Trials Pharmaceuticals Treatment 52

Practical Cheminformatics

MARCH 12, 2023

When working on drug discovery projects, it's handy to have access to a set of chemical structures and associated data for marketed drugs. If you're considering introducing new functionality, someone invariably asks whether that functionality has been used in a marketed drug. Download the ChEMBL database.

Drugs 52

Drugs Marketing Pharmaceuticals 52

Alta Sciences

SEPTEMBER 12, 2024

Case Study: Innovative Nanosuspension Approach to Maximize API Potency in Preclinical Formulation Development aasimakopoulos Thu, 09/12/2024 - 20:51 Download a copy of this case study.

Pharmacokinetics 52

Pharmacokinetics Compliance Pharmaceuticals FDA 52

PPD

MARCH 26, 2024

The PPD clinical research business of Thermo Fisher Scientific conducts an annual survey of more than 150 leaders at pharmaceutical companies around the globe to assess trends in drug discovery and development, including preferences around outsourcing and functional service provider (FSP) utilization.

Clinical Research 98

Clinical Research Clinical Development Pharmaceutical Companies Drug Development 98

Agency IQ

JULY 7, 2023

What is the state of pharmaceutical quality in the U.S.? Call it murky A new report published by the FDA’s Office of Pharmaceutical Quality (OPQ) promises a look at the current “State of Pharmaceutical Quality.” Read AgencyIQ’s analysis of the 2020 OPQ pharmaceutical quality report here.]

Pharmaceuticals 40

Pharmaceuticals Science FDA Production 40

The Pharma Data

NOVEMBER 16, 2020

Download Your Copy. We respect your privacy, by clicking “Download Your Copy” you will receive our e-newsletter, including information on Podcasts, Webinars, event discounts, online learning opportunities and agree to our User Agreement. Download Your Copy. Download Your Copy.

Science 52

Science Production Pharmaceuticals Marketing 52

PPD

NOVEMBER 18, 2024

However, in the modern biotech and pharmaceutical industry, a PV RI team needs to do more than just monitor ever-changing regulations. Given the multinational nature of many biotech and pharmaceutical companies, conducting business in multiple countries with multiple vendors is not uncommon.

Clinical Trials 52

Clinical Trials Regulations Compliance Production 52

The Pharma Data

OCTOBER 26, 2020

27, 2020 /PRNewswire/ — Aridis Pharmaceuticals, Inc. Dr. Hasan Jafri , Chief Medical Officer of Aridis Pharmaceuticals, will be a speaker on a panel entitled “Direct Antivirals and Other Agents Against SARS-CoV2 Virus.” About Aridis Pharmaceuticals, Inc. Aridis Pharmaceuticals, Inc. SAN JOSE, Calif. ,

Pharmaceuticals 52

Pharmaceuticals Virus Hospitals Clinical Trials 52

The Pharma Data

JANUARY 27, 2021

28, 2021 /PRNewswire/ — CASI Pharmaceuticals (Formerly Known As EntreMed, Inc.). About CASI Pharmaceuticals. CASI Pharmaceuticals, Inc. The Company’s operations in China are conducted through its wholly-owned subsidiary, CASI Pharmaceuticals ( China ) Co., and BEIJING , Jan.

Pharmaceuticals 52

Pharmaceuticals Clinical Trials Licensing Licensing 52

Conversations in Drug Development Trends

APRIL 15, 2024

Worldwide Clinical Trials recently conducted a comprehensive research study, where we included 140 key industry-decision makers from biotech and pharmaceutical companies of all sizes. The Advantages of Midsize CROs In contrast to large CROs, midsize CROs like Worldwide Clinical Trials offer a unique value proposition to the market.

Clinical Trials 52

Clinical Trials Clinical Development Clinical Research Pharmaceutical Companies 52

Drug Channels

MAY 9, 2022

Emily Phillips, Reimbursement, Patient Advocate, & Government Affairs Leader Melissa Beatty, Director, Patient Services and Reimbursement, CTI Bio Pharma Chad Bower, Executive Director, Field Reimbursement & Oncology Solutions, US Market Access, Daiichi Sankyo, Inc. Download the full agenda and save your seat today!

Specialty Pharmacies 69

Specialty Pharmacies Pharmacy Pharmaceuticals Government 69

The Pharma Data

JANUARY 7, 2021

The pharmaceutical product landscape is rapidly and fundamentally changing with profound impact on research and development strategy and technology needs. DOWNLOAD TO LEARN MORE>>>> Source link.

Production 52

Production FDA Pharmaceuticals Marketing 52

Drug Channels

MAY 22, 2023

WHAT YOU WILL LEARN As expensive specialty therapies come to dominate drug spending, pharmaceutical manufacturers are paying a growing share of patents’ out-of-pocket costs for these prescriptions. Or, download this spreadsheet and email your registrants’ information to Tamra Feldman ( admin@drugchannels.net ).

Pharmacy 72

Pharmacy Drugs Marketing Therapies 72

The Pharma Data

JANUARY 13, 2021

“Receiving Fast Track designation is an important acknowledgment of the results of our COVID-19 laboratory research,” commented Leo Ehrlich, Chief Executive Officer at Innovation Pharmaceuticals. A preprint supporting Brilacidin’s COVID-19 treatment potential can be downloaded at the link below. Source link.

Clinical Trials 52

Clinical Trials Trials Treatment FDA 52

Drug Channels

NOVEMBER 8, 2020

You can download the complete agenda here. Visit www.informaconnect.com/trade-channel for further details and to register. Drug Channels readers will save $200 off the standard rate when they use code KTP933 and register prior to November 20th.*. Stuart Parker, Senior Director, Trade Relations, Mayne Pharma And more!

Specialty Pharmacies 52

Specialty Pharmacies Science Pharmacy Pharmaceuticals 52

Drug Channels

MAY 3, 2021

Drug Channels readers are eligible for an exclusive savings of 10% off * the standard rate by using promo code 21CCCDC10 , so download the complete conference agenda and reserve your seat today! Expires 6/25/20210; applies to standard rate only and may not be combined or applied to existing registrations; other restrictions may apply.

Pharmacy 40

Pharmacy Pharmaceuticals Government Science 40

PPD

AUGUST 16, 2023

However, as the world settles into its post-pandemic state and returns to pre-pandemic paradigms in many areas, the pharmaceutical industry remains dedicated to moving beyond traditional, centralized clinical trial constructs. Study sponsors need quality results as quickly as possible to maximize profit-generation opportunities in the market.

Clinical Trials 98

Clinical Trials Trials Clinical Research FDA 98

PPD

OCTOBER 12, 2023

There are over 2,000 CGTs currently being evaluated in clinical trials, with more than 200 in Phase III and 10-20 per year estimated to come to market by 2025. Emerging areas of pharmaceutical research not only bring novel opportunities but also new regulatory guidance.

Laboratories 52

Laboratories Protein Expression Clinical Trials Pharmacokinetics 52

Perficient: Drug Development

JULY 11, 2023

Perficient is listed as a medium-sized consultancy with our industry focus being industrial products, pharmaceuticals and medical equipment, and retail. This report recognizes that “the market for commerce services is expanding rapidly as companies amp up their direct and digital commerce priorities.”

Marketing 40

Marketing Pharmaceuticals Production Research 40

Drug Channels

MARCH 19, 2023

Drug Channels readers are eligible for an exclusive savings of 10% off * the standard rate by using promo code 23DC10 , so download the complete conference agenda and reserve your seat today! Benefit from a fireside chat, in-depth sessions and learning streams, plus additional networking opportunities!

Science 57

Science Government Pharmaceuticals Drugs 57

The Connected Lab

MAY 4, 2022

A cornerstone of digital transformation, these solutions are accelerating the transition to Pharma 4.0 – a future vision of the pharmaceutical industry characterized by smart production workflows, flexible value chains and real-time process optimization.

Laboratory Informatics 52

Laboratory Informatics Laboratories Pharmaceutical Companies Pharmaceuticals 52

The Pharma Data

JANUARY 25, 2021

Maypharm is focusing on outstanding pharmaceutical products to provide superior botulinum toxin product with an up-to-date technological advantage and elaborated advanced manufacturing quality system and sophisticated equipment to meet the GMP requirements of the Agency’s CGMP regulations. For more information visit www.maypharm.net.

Production 52

Production Clinical Trials Marketing Regulations 52

Drug Channels

OCTOBER 26, 2020

You can download the complete agenda here. Download the agenda to plan your sessions and wrap up your week armed with critical updates and valuable takeaways. Visit www.informaconnect.com/gtn for further details and to register.

Government 40

Government Pharmaceuticals Science Production 40

Drug Channels

OCTOBER 19, 2020

You can download the complete agenda here. Download the agenda to plan your sessions and wrap up your week armed with critical updates and valuable takeaways. Visit www.informaconnect.com/trade-channel for further details and to register. Visit www.informaconnect.com/trade-channel for further details and to register.

Specialty Pharmacies 52

Specialty Pharmacies Science Pharmacy Licensing 52

The Pharma Data

AUGUST 19, 2020

19, 2020 /PRNewswire/ — Johnson & Johnson (NYSE:JNJ) today announced it has entered into a definitive agreement to acquire Momenta Pharmaceuticals, Inc. Janssen expects nipocalimab to contribute to its goals of achieving above-market growth over the mid and long term. NEW BRUNSWICK, N.J. , Learn more at www.jnj.com.

Disease 40

Disease Pharmaceuticals Treatment Pharmaceutical Companies 40

Conversations in Drug Development Trends

MARCH 7, 2024

When conducting first-in-human (FIH) clinical trials, small to midsize pharmaceutical and biotechnology companies are faced with several crucial choices that can shape the trajectory of their drug development pathway. For additional insights, download our full white paper, “ First-in-Human Studies: IND or CTA? ”.

Clinical Trials 52

Clinical Trials Trials FDA Drug Development 52

Drug Channels

NOVEMBER 23, 2020

Expires 12/16/2020; applies to standard rate only and may not be combined or applied to existing registrations; other restrictions may apply.

Pharmaceuticals 40

Pharmaceuticals Drugs Marketing 40

H1 Blog

NOVEMBER 15, 2023

Since KOLs play such a critical role, engaging with the right KOLs is a key strategy for pharmaceutical companies to stay ahead of the game. Compliance ensures that interactions between pharmaceutical companies and KOLs are transparent, fair, and free from any undue influence.

Compliance 59

Compliance Science Regulations Pharmaceutical Companies 59

The Pharma Data

OCTOBER 27, 2020

ASP5354 is an investigational compound discovered by Mie University and Nagoya University, with Astellas acquiring exclusive development and marketing rights worldwide. is a pharmaceutical company conducting business in more than 70 countries around the world. For more information, please visit [link].

FDA 52

FDA Pharmaceuticals Production Clinical Trials 52

The Pharma Data

MAY 3, 2021

The share repurchase authorizations permit shares to be repurchased in a variety of methods, including open market purchases, accelerated share repurchases, or other privately negotiated transactions. View original content to download multimedia: [link]. Purchases may be made from time to time at management’s discretion.

Pharmaceuticals 52

Pharmaceuticals Disease Marketing Research 52

PPD

JULY 9, 2024

Biotech and biopharma companies, however, must do all of this in the face of wildly fluctuating workloads — particularly during the post-marketing phase. Download our white paper The post FSP Flex Hub Teams Maximize Efficiency Across Lifecycle Maintenance appeared first on PPD. However, completing this work is only half the challenge.

Compliance 52

Compliance Production Clinical Research Marketing 52